CA2417885A1 - Cell internalized peptide-drug conjugates - Google Patents

Cell internalized peptide-drug conjugates Download PDF

Info

Publication number
CA2417885A1
CA2417885A1 CA002417885A CA2417885A CA2417885A1 CA 2417885 A1 CA2417885 A1 CA 2417885A1 CA 002417885 A CA002417885 A CA 002417885A CA 2417885 A CA2417885 A CA 2417885A CA 2417885 A1 CA2417885 A1 CA 2417885A1
Authority
CA
Canada
Prior art keywords
peptide
icam
drug
conjugate
binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
CA002417885A
Other languages
English (en)
French (fr)
Inventor
Teruna J. Siahaan
Helena Yusuf-Makagiansar
Meagan Anderson
Rong Christine Xu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of Kansas
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Publication of CA2417885A1 publication Critical patent/CA2417885A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/62—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being a protein, peptide or polyamino acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
CA002417885A 2000-08-01 2001-08-01 Cell internalized peptide-drug conjugates Abandoned CA2417885A1 (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US62971900A 2000-08-01 2000-08-01
US09/629,719 2000-08-01
PCT/US2001/024088 WO2002009649A2 (en) 2000-08-01 2001-08-01 Cell internalized peptide-drug conjugates

Publications (1)

Publication Number Publication Date
CA2417885A1 true CA2417885A1 (en) 2002-02-07

Family

ID=24524196

Family Applications (1)

Application Number Title Priority Date Filing Date
CA002417885A Abandoned CA2417885A1 (en) 2000-08-01 2001-08-01 Cell internalized peptide-drug conjugates

Country Status (5)

Country Link
EP (1) EP1311280A4 (de)
JP (1) JP2004505029A (de)
AU (1) AU2001278113A1 (de)
CA (1) CA2417885A1 (de)
WO (1) WO2002009649A2 (de)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2006227133A1 (en) * 2005-03-22 2006-09-28 Georgetown University Delivery systems and methods for diagnosing and treating cardiovascular diseases
EP2670421B1 (de) * 2011-02-02 2017-12-06 Medipost Co., Ltd. Verwendung von icam-1 zur prävention oder behandlung neurologischer erkrankungen
EP3497452A4 (de) 2016-08-12 2020-01-22 Immunowork, LLC Diagnose, prävention und/oder behandlung von autoimmunerkrankungen

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5183805A (en) * 1990-08-13 1993-02-02 Board Of Regents, The University Of Texas System Bioactive egf peptides for promotion of tissue regeneration and cancer therapy
WO1995028170A1 (en) * 1994-04-19 1995-10-26 The University Of Kansas Icam-1/lfa-1 short-chain peptides and method of using same
CA2252468A1 (en) * 1996-04-26 1997-11-06 The University Of Kansas Peptide compositions which induce immune tolerance and methods of use

Also Published As

Publication number Publication date
WO2002009649A8 (en) 2002-08-01
AU2001278113A1 (en) 2002-02-13
EP1311280A2 (de) 2003-05-21
WO2002009649A2 (en) 2002-02-07
JP2004505029A (ja) 2004-02-19
EP1311280A4 (de) 2005-02-23
WO2002009649A3 (en) 2002-04-11

Similar Documents

Publication Publication Date Title
EP0758383B1 (de) Lösliche polypeptidfraktionen des lag-3-proteins; verfahren zur herstellung; therapeutische zusamensetzung; antiidiotypischer antikörper
JP5670961B2 (ja) ＳｈＫトキシンを含む組成物
Kupfer et al. Small splenic B cells that bind to antigen-specific T helper (Th) cells and face the site of cytokine production in the Th cells selectively proliferate: immunofluorescence microscopic studies of Th-B antigen-presenting cell interactions.
Ross Regulation of the Adhesion versus Cytotoxic Functions of the Mac-1/CR3/α M β 2-lntegrin Glycoprotein
JPH09503511A (ja) 細胞および血清タンパク質アンカー並びに接合体
Zheng et al. A peptide-based material platform for displaying antibodies to engage T cells
Moingeon et al. Complementary roles for CD2 and LFA‐1 adhesion pathways during T cell activation
EP0607332B1 (de) Vorbeugungsmethode oder behandlung von, durch antigen-präsentierende zellen hervorgerufene, hautkrankheiten mittels inhibitoren der cd2/lfa-3 wechselwirkung
Lagaudrière‐Gesbert et al. Signaling through the tetraspanin CD82 triggers its association with the cytoskeleton leading to sustained morphological changes and T cell activation
Seaman et al. Inositol trisphosphate is generated by a rat natural killer cell tumor in response to target cells or to crosslinked monoclonal antibody OX-34: possible signaling role for the OX-34 determinant during activation by target cells.
Rao et al. Potent costimulation of effector T lymphocytes by human collagen type I
CA3032826A1 (en) Compositions and methods for modulating lair signal transduction
Lundblad et al. The interaction of thrombin with blood platelets
AU751151B2 (en) T-cell membrane protein (TIRC7), peptides and antibodies derived therefrom and uses thereof
Gürsoy et al. Binding and internalization of an ICAM‐1 peptide by the surface receptors of T cells
Jenkins et al. Characterization of the receptor responsible for thrombin-induced intracellular calcium responses in osteoblast-like cells.
DE69529515T2 (de) Die regulation der aktivität zytotoxischer t-zelllymphozyten mit peptiden der mhc-klasse i
US5645837A (en) Peptides that inhibit T cell activation and methods of using the same
Yusuf-Makagiansar et al. Inhibition of the adherence of T-lymphocytes to epithelial cells by a cyclic peptide derived from inserted domain of lymphocyte function-associated antigen-1
CA2417885A1 (en) Cell internalized peptide-drug conjugates
Gonzalez et al. Transendothelial migration enhances integrin-dependent human neutrophil chemokinesis
JP2003128579A (ja) 特定種のｌｆａ−３またはｃｄ２結合蛋白質を投与することによる同種移植または異種移植の寛容性を改善するための方法
Manikwar et al. Utilization of I-domain of LFA-1 to Target Drug and Marker Molecules to Leukocytes
Yusuf-Makagiansar et al. Synergistic inhibitory activity of α-and β-LFA-1 peptides on LFA-1/ICAM-1 interaction
Liu et al. A novel, rapid and sensitive heterotypic cell adhesion assay for CD2–CD58 interaction, and its application for testing inhibitory peptides

Legal Events

Date Code Title Description
FZDE Dead